Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 71.67%126.41B | 97.18%79.48B | 99.26%35.93B | 31.70%108.17B | 18.58%73.63B | -2.86%40.31B | -10.25%18.03B | -12.94%82.13B | -17.13%62.1B | -22.49%41.5B |
| Refunds of taxes and levies | 215.76%4.15B | 274.80%2.49B | 204.39%1.22B | -34.99%2.12B | -43.30%1.31B | -54.01%664.75M | -50.06%400.67M | -32.57%3.26B | -38.96%2.32B | -37.47%1.45B |
| Cash received relating to other operating activities | -51.33%1.59B | -72.39%864.5M | 69.53%603.08M | 119.04%2.78B | 8.88%3.27B | 61.43%3.13B | 75.77%355.74M | -25.54%1.27B | 226.32%3.01B | 45.63%1.94B |
| Cash inflows from operating activities | 68.95%132.15B | 87.82%82.84B | 100.94%37.75B | 30.46%113.07B | 16.02%78.22B | -1.73%44.11B | -10.94%18.79B | -14.09%86.67B | -15.35%67.42B | -21.51%44.88B |
| Goods services cash paid | 75.11%120.88B | 103.66%77.46B | 122.47%35.11B | 38.51%100.32B | 26.34%69.03B | 1.07%38.03B | -9.16%15.78B | -17.74%72.43B | -22.26%54.64B | -27.13%37.63B |
| Staff behalf paid | 34.95%7.65B | 34.85%4.66B | 61.35%2.52B | 14.49%7.62B | 9.23%5.67B | 8.84%3.45B | -1.24%1.56B | 4.35%6.66B | 10.68%5.19B | 3.11%3.17B |
| All taxes paid | 52.23%1.04B | 34.46%656.37M | 1.33%295.69M | 8.69%1.01B | -3.02%680.46M | -6.07%488.14M | 19.26%291.81M | 10.52%931.1M | 12.76%701.67M | 29.09%519.68M |
| Cash paid relating to other operating activities | 100.53%3.41B | 45.77%1.59B | 659.28%1.24B | -2.15%2.74B | -67.28%1.7B | -39.57%1.09B | -82.54%162.75M | -8.15%2.8B | 130.66%5.19B | 54.92%1.8B |
| Cash outflows from operating activities | 72.52%132.98B | 95.89%84.36B | 120.04%39.16B | 34.87%111.69B | 17.28%77.08B | -0.14%43.07B | -11.59%17.8B | -15.76%82.82B | -15.58%65.72B | -23.38%43.13B |
| Net cash flows from operating activities | -172.57%-826.83M | -246.20%-1.52B | -242.39%-1.41B | -64.26%1.38B | -32.90%1.14B | -40.74%1.04B | 2.73%990.08M | 49.96%3.85B | -5.84%1.7B | 95.87%1.76B |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | -19.82%6.54B | -19.90%3.55B | 2.64%1.85B | 38.42%11.4B | 36.48%8.15B | 129.91%4.44B | 501.89%1.8B | 79.01%8.24B | 1,157.21%5.97B | 587.88%1.93B |
| Cash received from returns on investments | 204.93%295.25M | 67.55%127.39M | -23.00%31.76M | 163.82%147.38M | -54.73%96.82M | -56.12%76.03M | 10,772.85%41.24M | -64.89%55.86M | 1,520.45%213.89M | 1,313.98%173.25M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 75.47%65.67M | 37.35%51.35M | 1,167.77%9.45M | -2.94%18.56M | -27.11%37.42M | -12.35%37.39M | -94.37%745.69K | -42.04%19.12M | 69.26%51.34M | 54.11%42.66M |
| Net cash received from disposal of subsidiaries and other business units | ---- | ---- | ---- | --4.86M | --10.9M | ---- | ---- | ---- | ---- | ---- |
| Cash received relating to other investing activities | ---- | ---- | 0.32%916.75K | ---- | ---- | ---- | --913.81K | -58.90%1.18M | --913.81K | --600K |
| Cash inflows from investing activities | -16.87%6.9B | -17.97%3.73B | 2.53%1.89B | 39.21%11.57B | 32.99%8.3B | 112.01%4.55B | 489.39%1.84B | 73.32%8.31B | 1,103.00%6.24B | 569.73%2.15B |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | 85.43%2.53B | 54.98%1.48B | 85.92%681.69M | 41.10%2.07B | 30.63%1.37B | 25.67%952.72M | -15.14%366.65M | -38.06%1.46B | -48.09%1.05B | -35.45%758.1M |
| Cash paid to acquire investments | 0.86%8.01B | 26.04%4.91B | 99.06%3.32B | 4.24%10.61B | 10.21%7.94B | 110.86%3.9B | 13.95%1.67B | 80.84%10.17B | 93.01%7.2B | 61.93%1.85B |
| Net cash paid to acquire subsidiaries and other business units | 640.68%1.61B | -29.26%32.01M | -29.26%32.01M | --2.52B | --217.59M | --45.26M | --45.26M | ---- | ---- | ---- |
| Cash paid relating to other investing activities | --179.79 | -99.94%62.64 | 36,144.40%9.16M | -98.59%1.23K | ---- | 13,586.30%106.54K | 11,873.84%25.26K | 3,714.25%87.41K | 300.56%4.47K | -23.87%778.44 |
| Cash outflows from investing activities | 27.61%12.15B | 31.16%6.42B | 94.38%4.04B | 30.54%15.19B | 15.44%9.52B | 87.82%4.9B | 9.70%2.08B | 45.65%11.64B | 43.56%8.25B | 12.54%2.61B |
| Net cash flows from investing activities | -329.15%-5.25B | -680.65%-2.69B | -816.27%-2.15B | -8.86%-3.62B | 39.07%-1.22B | 25.11%-344.25M | 85.17%-234.56M | -4.10%-3.32B | 61.57%-2.01B | 76.96%-459.68M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | 254.83%263.93M | 294.32%246.34M | 42.27%88.88M | -98.71%74.38M | -98.70%74.38M | --62.47M | --62.47M | --5.76B | --5.73B | ---- |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | --157.46M | --157.46M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from borrowing | -22.53%21.7B | 90.03%24B | 653.07%15.37B | 89.51%20.29B | 158.31%28B | 102.86%12.63B | -78.36%2.04B | -49.81%10.71B | -46.47%10.84B | -50.88%6.23B |
| Cash received relating to other financing activities | 6,671.49%180.86M | 10,383.07%280M | 21,220.28%100M | -78.10%192.67M | -92.62%2.67M | -99.63%2.67M | -96.59%469.04K | 291.00%879.74M | --36.19M | 185.46%713.91M |
| Cash inflows from financing activities | -21.15%22.14B | 93.20%24.53B | 639.51%15.55B | 18.49%20.56B | 69.08%28.08B | 82.93%12.69B | -77.73%2.1B | -19.53%17.35B | -17.99%16.61B | -46.30%6.94B |
| Borrowing repayment | -41.39%13.54B | 49.30%16.53B | 1,277.30%10.85B | 39.70%14.7B | 145.32%23.11B | 89.51%11.07B | 477.93%787.81M | -44.46%10.52B | -11.87%9.42B | -44.81%5.84B |
| Dividend interest payment | 15.89%1.33B | 11.07%1.11B | 93.86%89.33M | 505.73%1.07B | 591.68%1.15B | 810.96%1B | 10.03%46.08M | -27.58%175.91M | -2.14%165.61M | 22.39%109.97M |
| Cash payments relating to other financing activities | -26.99%1.83B | 138.29%2.3B | -35.67%1.22B | 18.98%1.44B | 165.00%2.5B | 1,979.78%965.33M | -72.87%1.9B | 9.35%1.21B | -64.49%943.89M | -3.33%46.42M |
| Cash outflows from financing activities | -37.59%16.7B | 52.95%19.95B | 344.58%12.16B | 44.48%17.21B | 154.11%26.76B | 117.36%13.04B | -61.94%2.74B | -41.32%11.91B | -22.10%10.53B | -44.06%6B |
| Net cash flows from financing activities | 310.87%5.44B | 1,424.76%4.58B | 635.93%3.39B | -38.42%3.35B | -78.21%1.32B | -136.77%-345.76M | -128.07%-632.66M | 331.71%5.44B | -9.75%6.08B | -57.25%940.2M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -54.17%80.33M | 295.13%236.62M | 295.08%115.09M | 138.45%90.2M | -30.08%175.26M | -148.38%-121.26M | -77.32%29.13M | -821.19%-234.61M | -12.00%250.65M | 24.47%250.65M |
| Net increase in cash and cash equivalents | -139.31%-556.35M | 163.88%607.24M | -135.04%-53.27M | -79.14%1.19B | -76.48%1.42B | -90.75%230.12M | -91.39%152M | 843.15%5.73B | 67.34%6.02B | 91.06%2.49B |
| Add:Begin period cash and cash equivalents | 11.68%11.43B | 11.68%11.43B | 11.68%11.43B | 127.20%10.23B | 127.20%10.23B | 127.20%10.23B | 127.20%10.23B | 15.59%4.5B | 15.59%4.5B | 15.59%4.5B |
| End period cash equivalent | -6.67%10.87B | 15.02%12.03B | 9.53%11.37B | 11.68%11.43B | 10.69%11.65B | 49.62%10.46B | 65.66%10.38B | 127.20%10.23B | 40.43%10.52B | 34.50%6.99B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.